HCC podcast series part 1: The use of IO in unresectable HCC

November 21, 2024 00:23:21

Show Notes

In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use of IO (immunotherapy) in unresectable HCC (uHCC) and take a deep dive into the different treatment options first-line focusing on IO and IO based combinations. Topics include: 

 

 

Key clinical takeaways:

 

 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/hcc-connect  

X: https://x.com/hccconnectinfo  

 

This content is intended for healthcare professionals only.  

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. AstraZeneca has provided a sponsorship grant towards this independent programme. 

 

This podcast is developed by cor2ed.com 

Published on November 2024 

 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

March 21, 2025 00:26:13
Episode Cover

Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.   Dr Rena Callahan and Dr Roberto Salgado...

Listen

Episode

December 07, 2023 00:22:35
Episode Cover

Precision oncology: An overview of tumour agnostic therapies

What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...

Listen

Episode

May 28, 2024 00:21:47
Episode Cover

Regional differences in NET: Epidemiology, diagnosis, and referral strategies

In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient...

Listen